SCHEMBL4893850

SCHEMBL4893850

CCOC(=O)c1c(-c2ccc3[nH]ccc3c2)c2cc(N)ccc2n1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.46
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
PKM P14618 1/20 0.43
ENPP2 Q13822 1/20 0.42
KMT2A Q03164 1/20 0.41
MAOA P21397 1/20 0.41
MDM2 Q00987 2/20 0.41
MDM4 O15151 1/20 0.41
MAPK14 Q16539 2/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TNIK Q9UKE5 2/20 0.40
F10 P00742 1/20 0.40
S1PR3 Q99500 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893855 0.87 HRH3 (0.48) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL4887461 0.86 AR (0.51) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL4886339 0.86 PLA2G2A (0.55) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL4893009 0.84 PLA2G2A (0.51) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL4887373 0.82 SERPINE1 (0.55) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL5415705 0.75 MAPK8 (0.52) MAPTKDM4ELMNAGAAPKM
SCHEMBL4887465 0.74 AR (0.50) PLA2G2AMAPTKDM4ELMNAGAA
SCHEMBL6858375 0.72 KMT2A (0.47) PLA2G2AKMT2A
SCHEMBL5172795 0.72 KMT2A (0.50) MAPTKDM4ELMNAGAAPKM
SCHEMBL5173704 0.72 KMT2A (0.50) MAPTKDM4ELMNAGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US disclosed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US disclosed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES STS, TPST2, IDO2 PLA2G2A 3606/4885MAPT 2124/4885KDM4E 1990/4885
US-20050096377-A1 Substituted sulfonamide-indoles STS, TPST2, IDO2 PLA2G2A 3606/4885MAPT 2124/4885KDM4E 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.